SEC Form 4 · accession 0001140361-15-001719
Relypsa Inc · RLYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Klaus R Dr Veitinger
Director
Period of report
Jan 12, 2015
Accepted (ET)
Jan 14, 2015 · 11:15 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001416792
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 12, 2015 | M | 5,834 | $4.65 | A | 8,546 | D | |
| Common StockF3,F1 | Jan 12, 2015 | S | 4,386 | $32.1718 | D | 4,160 | D | |
| Common StockF4,F1 | Jan 12, 2015 | S | 1,448 | $32.7922 | D | 2,712 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $4.65 | Jan 12, 2015 | M | 5,834 | D | — | Oct 31, 2020 | Common Stock | 5,834 | 21,960 | D |
Explanation of responses
- F1Includes 2,712 restricted stock units.
- F2The sales reported in this Form 4 were effected pursuant to the Reporting Person's personal Rule 10b5-1 trading plan.
- F3The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $31.70 to $32.63, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F4The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.7067 to $32.90, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F5100% of the shares subject to the option are fully vested and exercisable.